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Abstract. A ωtot，ωal of 24 加benのrylimidtαlwl!ι紡 sand structural~ tannin) (2-4) and isoprenylated flavonoids (5， 6) induced舵 zo 必 κω ち}九 
rel.伐ばdcom伊!pounds例附t館 μα 
G 総'Jtoral tumor αls and nonnal gingival fibroblast.略g終 aIl間Z
Cmηpound 23 βイ2hydroxヂ Ibenzoyl)-2網 phenylimidazole)sho・繍 
wed the highest cytotoxic activity against both human oral tumor 
cel lines (human squamous cel carcinoma HSC-2， hur加 n 
salivary gland tumor HSG) and nOl附?符初na滋lhumα ♂伊1仰 ngmg口附vyωa
戸broblas 幻').必 t(HGF Compoumls 7 βイ 2・hydro.実 ybenzoyl)benz 
imidazo[2，1ゐ ]thiazole)， 14 (1，ふ diethyl-5イ 2-hydroλybenzoyl)イ舗 
imidazolineふ thione)and 18 (5イ 2-hydroxy-4-methα xybenzoyl)倫 
3-methyl-2.・met}そylimino・4-thiawline) showed slightly lower 
の'totoxicactivity，buth努 hertumor-specific cytotoxiε action. The 
cytotoxic activiぴ ofcompound 23 was sigm芦 cantiyreduced by 
CUCl2 but not by CoCh FeCI3，or by antioxidants (N-acetyl-L-
cysteine， sodium ascorbate， catalase). Compound 23 did not 
show αny detectable 0.克 idationpotential (determined by NO 
monitor). Agarose gel electrophoresis demonstrated that corト 
pound 23 induced DNA fragmentation in human prom狩 locytic 
/eukemia cels HL-60， but not in HSG cels. These data 
suggested that the response ω compound 23 might be different 
from cel to ce以 
We have recently summarized the efficacy of polyphenols in 
preventing oral diseases (1). Our strategy include the 
following three steps: (i) screening of various natural and 
synthetic compounds， (i) elucidation of action mechanism 
珪 nd，りi) interaction with the oral environment. We have 
recently found that tannins，such as macrocyclic hydrolyzable 
tannins， epigallocatechin gallate (EGCG) 伊 major 
∞ mpo登記 ntof green tea)， gallic acid (a compon四 tunit of 
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~re m泌 εst伊舵 v俗剖 iぜド印iμicactx.厄Oωto卯制釧hacy，仇r'o舟te vれかdj t fωε げ iかrの 必昨似2 品 poptoticcel death， characterized by DNA fragmentation 
(抗出缶詰 dby TUNEL method and agarose gel electro-
phoresis) 部 d caspase activation (identぽ ied by 挺 30 
monovlonal a設 tibody)，in human oral tumor cels. 仁 ignins， 
which had litt1e cytotoxic activity， syner喜 istical1ystimulated 
the cytotoxic activity of sodium ascorbate (7). We have 
r己 cently reported that newly synthesized benzoxepin/ 
benzothi悲 pininduced tumor-specific cytotoxicity and inter-
nucleosomal DNA fragmentation，a biochemical h必 Imarkof 
apoptosisラ in oral tumor 民 1 lines (8). These findings 
prompted us to initiate the structure-activity relationship of 
various synthetic compounds，for their clinical注 pplication. 
Imi泌dazol(ine吟) de 泌 ti 勾ylcolir ir泌叫 ed釘出ri:討vaおV己郡sinhibit the 昌 cet 出le司 
s邑伐cr民巴飢凶tio怠 of ぬhね対01設淑組1伺catωec 紅mi 
blocki泌ngnicotinic ac竹ylchね 問1潟er伐詑 ptωors(ο10 These drugs印己 t 恥ol 隠 eclir 的)‘ 
were previously reported to act as (l l-adenoceptor anta欄 
gonists. Also， imidazol(ine) derivatives have been shown to 
be neuroprotむ ctivein brain injuries of necrotic (11) and 
apoptotic neuronal cel 成立 th(12). Previo出 ly， the neuro-
protective effects of imidazolines against Nmethyl-D網 
aspartate (NMDA)-indむ ced neurotoxicity in cultured 
cerebellar gra部 lecels (13，14) have been reported. These 
imidazol(ine) derivatives possibly show the broad spectrum of 
biological effects on primary or permanent ce1s ap在 rtfrom 
the cels described above. We report here the relative 
potency of 5-benzoylimidazole and related ∞ mpound，(15) to 
induce cytotoxicity against human or註 1 squamous cel 
carcinoma ce1Js HSC-2 and human salivary gland tumor ce1s 
HSG，in comparison with human normal gingival fibrol予last 
HGF and human promyelocytic leukemia HL-60 cels“ 
Materials and Metho出 
Materials. The foIlowing reagent~ were obtained from the indicated 
compa註 ies:Dulbecco's modified五 aglemedium (DMEM)， RPMI1 640 
medium (Gibco BfミL， Gland Island， NY， USA); fetal bovine serum 
(FBS)(JRH Biosic， Lenexa， KS， USA); CoCI2'6H20， FeCI3'6H20， 
C註 ClnH20，dimethyl sulfoxide (ひ MSO)(WakoPure Chem. Ind. Ltd.， 
Osakaラ Japan)， 3叩 μ，5必在 lethylthiazol-2-yl)“ 2 
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mmol)ラ .50em.lnd.設岱(SigmC)(NA制cyste心Nacetyl，ctaJase畠，bromide (MTI) 晶 
St. Louis多 MO，USA); RNa担 A，proteinase K (Boehri誌が rMannheim 
Ge際n泌淑鵬桜総Eり).絞 r焔l昆lya
Synthesis 01 3-azoかlthio・ 4H-1み enzopyran-4ωoneand 2-benzoylimid，αzo 
[2，1-b}thiazole (general procedure A). A mixture of 3-iodochromone 
(136 mg，0.5 mmol)，mercaptoazoles (0.5 mmol) and KZC03 (276 mg， 
2 mmol) in DMF (5 mL) was stirred for ト 4ho註 rsat room 
temperat詰 re.After removal of the K2C03，the re昌記録。 nmixture was 
dilut誌 dwith water詞 ndextracted with CHCI3・ Theorganic layer was 
dried over Na2S04 and the solvent was evaporated under reduced 
pressure. The residue was purified by silica gel column chroma-
tography (hexane-AcOEt). 
Synlh白 is013イ 1子 benzimidazolふ ylthia)-4H-1-benz~汐ran-4・ one (1) and 
2イ 2・hydro:xヂbenzoyl)benzimidazo[2，1-b}thiazole (7). According to the 
車問 eralprocedure A， 3・ iodochromone(13毛 mg， 0.5 mmol) 昌 nd2-
mercaptobe回 imid昌 zole(75 mg，0.5 mmol) were treated with K2C03 for 
1hour to givc 1 (41 mg，28%) and 7 (88 mg，60%)，respective句集 
mmol) and K2C03 .50，4NC1(139 mg，日目thiourea(2 mmol)
ぴ 90mg， 5 mmol) in benzene (15 mL) w註 srefluxed for 10-18 hours 
Aftcr removal of K2C03，the reaction mixt日 rewas diluted with w在 ter 
and extracted with CHCI3. The org品説 iclayer was dried over Na2S04 
and the solve詰 twas evaporated under reduced press註 re.Th註 residue 
was purifi匙 dby siJica gel columnchromatography (hexaneωAcOEt). 
今 nthes問。 '1 5イ2-hydro.砂 Ibenzoyl)-1，3-dimethylふ imidazolineふ thione 
(11) and 5イ2-hydroxybenzoyl)-3例制!)I1-2-methylimino-4-thiazoline (16). 
According to the general pro∞ dure B，3-iodochromone (136 mg，0.5 
mmol) and 1，3-dimethyl-2-thioure昌 (208mg，2 mmol) were treatcd with 
K2C03 for 18 hours to give 11 (78 mg，63%) and 16 (33 mg，27%)，respe-
ctively. 
Synth削 s015イ 2-hydroxyl.ふ 均 oxylbenzoyl)-1，3-dimethyl-4-imidazoline-met，
2-thione (12) and 5-(2ωhydro.伊 5-methoxybenzoyl)-3-methyl-2-methyl嶋 
tmmo・ 4-thiazoline(17). According 10 the general proced註 reB，3-iodo時か 
methoxylchromone (151 rng，0.5 mmol)紛 d1，3-dimethylふ thiourea(208 
rng，2 mmol) wcre treatcd WIth KZC03 for 15 hours to give 12 (85 mg， 
61均 and17 (44 mg， respectively. 
Synth回 is 01 3イ 1H-benzmidazol-2ヴ.zth必 )-6-metho.勾 1-4H-l-benzopyran-4“ 
Sy 初tωts0 ふ 夫1凶d的4砂，問nth切es イ15イfρ2一JザV λ d郎U引4ω伊イenzo舵i砂ヂetωn1-4ω;y勿 イ繍刊州附 l仇hOJ:.めb のyひか輔イ1，3-dime仇 yl- 必αzol長，m財 e-one (2). According to the general procedure A，3-iodo-6・ methoxychrか 
2-t仇hi，ωon附 e α13 却 d(幻j -1fρ2時悶イ.5 
俗 zot.台P配e(の'). Accordin墨 to the general procε dure B，3-iodo-7-紛i μ18附1
勾そザydra勺予y-4αzmon己 (151mg，0.5 mmoJ) and 2-mercaptobenzimidazole (75 mg，0.5 
4-ft眠イlmlnO 治j先lia
methoxylchromone (151 mg，0.5 mmol)釦 d1，3-di期総担詳細 2・ thiourea(208 
mg，2 mmol) were treated with K2C03 for 10 ho詰 rsto give 13 (174 mふ
mmol)were tre詣 tedwith K2C03 for 4 h togive 2(139 mg，86%). 
Synthesis 013-(lHィ midazol・2-ylthio)イ H-ふ benzopyranふ one(3) and 2-ρ 
総%) and 18 (20 mg，14%)，rcspectively. 
4).(1thione 2ω即時4-imidazoli・enzoyl)考会ro.2-hydイ53-diethyl，nthesis01 1今 繍 
hydro.勾 Ibenzoyl)imidazo[2，l-b}thiazole (10) According10 the general剛 
proce出 reA， 3-iodochror恐慌 e(136 mg， 0.5 部 nol) and み merca-
ptoimidazole (50 mg，0.5問問 1)were tre畠 tedwith K2C03 for 1hour to 
According to the general procedure B，3-iodochromone (136 mg，0.5 
mmol) and 1，3-diethyl-2-thiourea (264 mg，2 mmol) were treated with 
h∞ 3for 14 hours to give 14 (124 mg，90%) 
give3 (22 mg，18%) and 10 (76 mg，62%)，respectively 
Synth削 is013-(l-methyl-1H-開 :idazol-2ヅ Ilhio)-4H-lみ enzopyran-4-one(4)喰 
According to the gener註 1procedure A， 3-iodochromone (136mg， 0.5 今 nth目白 015イ 2倫 hydroxybenzoyl)-1，3-diphenyl-4・imidazoline-2仇 ione(15). 
mmol) a詞 d2-mercaptoふ E制御 limidazolむ (57mg， 0.5 mmol) were Acむ ordingto the general procedure 1弘 3ゐ iodochromone(136 mg， 0.5 
v 之 
treated with KZC03 for 1hour to give 4 (114 mg，88%). 
網Synthesis 01 3-(lH-l，2，4-triazol-3-ylthio)-4H-lbenzopyran-4-one (5) 
According to the general procedurな A，3-iodochromone (136 mg，0.5 
mmol) were treated .50，-triazole(51 mg，42，rcapto-l巴nd3-m昌mmol)
with K2C03 for 2 hours to give5 (88 mg，72%). 
今 mthesis01 3-(4・methylイ H-l，2，4-triazol棉 3-ylthio)-4Hイャ benzopyran-4 
one (6). According to the general procedure A，3-iodochromone (136 
mg， 0.5 mmol) and 3-mercapto・4-met註 ylω1ふ 4鴨川 azole(58 mg， 0.5 
mmoJ) were treated w出 K2C03for 2 hour器 togive 6 (91 mg， 
70'1も〉廻 
Synthesis 01 2イ 2‘hydroxybenzoyl)グ哨 ethoxybenzimidazo[2，I-b}thiazole 
(8). According to the general procedure A，3-iodochromone (136 mg， 
0.5 mmol)註詰 d2-mercapto-5-met主 oxyち己毘 zimidazole(90 mふ 0.5mmol) 
were treated with KzC03 for 1ho註 rto give 8 (73 mg，45%)‘ 
Synthesis 01 5H-benzimidazo[2'， 1う2， 3}thiazolo[4，5み '}benzopyranふ one 
(9). Toa stirred solution of 7 (84 mg，0.3 mmol) and DBU (182 m事，1.2 
mmol) in C珂 2Cb(3 mL)， a solution of iodine (84 mg，0.33 mmol) in 
CH2C12 (2 mL) wぉ drop剛 wiseaddcd over a 20 minutcs period at O'c. 
After bei担宰 stirredfor 10 minutcs， the reaction was守 uenchedat the 
噌same temperature by叫 di時 saturatedaqueous N在 2S203(2 mL) The 
mixture was extracted with CH2CIz， the combined organic layers were 
dried over Na2S04 and the solvent was evaporatcd under r己 duced 
prαsure. The rcsidue was purified by silic在 gelωlumn chromatography 
10 give 9 (81 mふ 92ちも) 
Synthesis 01 5-benzoyl-4-imidazolinψ2仇 ioneand 5-benzoyl-2-imi即時4 
thiazolineな eneralprocedure B). A mixture of 3-iodochromone (13岳 mg， 
1082 
mmol)品目 d1ふ dip泌 nyl必 thio註 re畠 (456mg，2 mmol)附 retreated with 
K2C03 for 15 hours to give 15 (1ωI時， 91%).
五.yn決 es浴 014，5，6，7-tetrahydroふ ρ-hydro.砂 benzoyl)pyrimido[2，1-b]thiazole 
(19). According to the ge設 eralprocedure B，3-iodochromone (136 mg， 
0.5 mmol) and 3ム 5撃か tetrahydro嚇 2やり imidinethiol(232 mg， 2 mmol) 
were treated with K2C03 in MeCN at rt for 6 hours to喜ive汐 (129mg， 
99%) 
斗IJlthesis01 5-benzoylimidazole (general procedure C). A mixture of 3・
言。 and K2C03(6，amidincs (2 mmol)，0.5 mmoI)，iodochromone (136 mg 
mg，5叩 nol)iDMF(10 mL) was stirred for 1-5 h atrt. After removal担 
of K2C03， the reaction mixture was diluted with water and eχtracted 
lentwith CHCb・す heorganic layer was dried over Na2S04 and the 801、 
was evaporated under reduc辛dpressure. The residue was purified by 
silica gel column chromatography (hexane-AcOEt). 
今IJlthesis015-(2-hydrcu手必 enzoyl)-2・ methylimidazole(20). According to 
the ger附註 1procedl出 C， 3-iodochromone (136 mg， 0.5 mmol) and 
acetamidir総長 ydrochloride(189 mg，2 mmol) were te在 tedwitお K2C03 
for 1hour to give 20 (93 mg，92%). 
今 nthesis 01 5イ 2鱒 hydroxy-5-methoxybeむの 1)-2-methylimidazole (21)， 
According to the general procedure C，3-iodo-6・ methoxychrornone(151 
mg，0.5 mrnol) and aωtamidine hydrochloride (189 mg，2 mmol) were 
6%).，ヲ treated with K2C03 for 2 hours to give 21 (111 mg
Synth白 is 01 ふ ρ-hydroxyふ methoxybenzoyl)ふ methylimidazole (22) 
According to the general proccdure C，3-iodoふ mcthoxychromone(151 
mg，0.5 mmol) and acetamidine hydrochloride (18争 mg， 2 mmol) were 
trcated withK2C03 for 3 hours to give 22 (111 mg，96%). 
Terasawaet al: 
! zo持Ithio-4件 1・加nzopyran倒的ne) 3喝
げ出杭 R2イ工〉
十4 1: R1おおH，R2:::1H-benzimidazol・2・yl




 3: Rl=H. R2=1H-imidazol-2γi or 
出4: R1=H，R21-methyl-1H-imidazol・2・ylH 
誌品 H， R2=な 5:R1H，R2型 1H・1，2，4網triazol-3-yl 
3-yl・-triazol之，41し=4-methyl-4HR2，高村16: R樹、N 
5: R'=H，R"= --4，NH 
N
N-N 
出6: Rl=H，R2 -JENF 
Me 
{2橿 benzoy刷 dazo[2，凶知治初陣 
7:円=H。;IF ひ ;xFqxp 8: R=OMe 
O 10 
|ふbenzoy同凶azo加や仙ne ) 15悦限切断悶Ino-4・蜘zoline) 
11: R1器 Me，R2出向3岩 H 16: R1=Me，R
2=R3=H:qIト12: R1口Me，R2=OMe，R3口H13: R1 司3=OMe ;qk〉Nn1 17:円l=Me，R2出 OMe，R3出 H18: R1出 出Me，R2H，R3=OMe=Me，R2=H，F
14: R1=Et，F司2=R3=H 19:R1口 (CH2h-，Fミ2:R3=H 
15: R1=Ph，R2=R3=H 









Fig立問 1. Strncture of 3-azoかthio-4H-1-benzopy叩 Fト 4-one (1・6)，み benzoylimidazo[2，1みJthiazole (7-10)，ふben:zoyl-4・imidazoline-2-thione(11.15)，5・ 
benzoylふ imino-4ィhiazoline (16.19) and5揃 benzoylimidazole(2ふ 24)， 
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Table t Cy印州Lω制0ωt肌0拙仰'xi化ca配 C丘許剥vばi的砂 and t奴umOl 
F陀ぜ f必αt絞ed co庁守vフO制 Il帥nd.ゐ s.
Compound 
qtotoxic activi守 (CCso: l-lg/m 1.). 
HSC-2 HSG H 1.-60 HGF 






2 15 76 
3 174 221 
4 >400 >400 
5 225 218 
吾 296 330 
2-benzoylimidazo{之 l必 lthiazole 
7 52 44 17 183 3.5 10.8 
畠 >400 231 
9 164 264 
10 152 244 
ふ benzoyl即ふ imidαzoline-ユ thione 
11 104 128 
12 75 145 
13 50 136 
14 59 35 27 141 2.4 5.2 
15 >400 310 
5-benzoyl-2-imino-4ω thiazoline 
16 104 87 
17 144 85 
18 149 13 10 >400 2.7 >40 
19 >400 295 
5-benzoylimidαzole 
2時 185 183 
21 191 247 
22 130 162 
23 27 18 4.2 24 0.89 5.8 
24 77 80 
Near confluent cells were incubated for 24 hours with variou器 
concentrations of位認知 dicatedcompounds“ The relative viable cel 
nurnber was then determined by the Mπmethod (HSC-2，HSG，HGF) 
or by If}引 nblむ eexclusion (H1.-60). Co抗柱。 1AS4号。 fHSCム HSGand 
HGF celIs were 1.376， 0.594昌 nd0.489， respectively. Each valω 
represents the mean from 2 independent experiments which were 
performed in duplicate 
compound 23. 
Cytotoxic activity of23 against HSG cells 
Addition (CCso・詳が詰1.) 
None (ω抗 troJ) 32 
+4mお 1NAC ;と号 
+ 0.25 mM sodium ascorbate 28 
十 30∞担割 it泊 1 catalase 30 
+ 0.2 mMCOCl2 35 
十弘之 mMFeCI3 28 
十 0.2mMCuC12 5.4 
Near confluent HSG cells were incubated for 24 hours with various 
conc側 trationsof compound 23 in the absence (∞持 trol)or prese抗 ceof 
the indicated concentration唱。f品約 tioxid品目 tsor metals. The relative 
viable ceU number was then determined bv the M玄寸 method10 c品 lculate 
Ihe CCso value. Conlrol AS40 of HSG cel1s was 1. 140. Each value 
represenls the mean frorn 2 deterrninations. 
Synthesis of 5イ 2-hydroxメ benzoyl)-2-phenylimidazole(23). According 10 
the general procedure C， 3-iodochromone (136 rng， 0.5 rnrnoJ) and 
benzamidine hydrochloride (313 rng，2 rnrnol) were treated with K2C03 
for 0.5 houぉ 10give 23 (128 rng，97引守 
Synthesis of 5-(2砂 hydroxylbenzoyl)-2-methylthioimidazoた (24). According 
to the general procedt江 'eC， 3-iodochrorno抗 e(136 rng， 0.5 rnrnol) and 
meth}品。 thioureasulfate (556 mg， 2 mmol) were treated with KZC03 
for 5 hours to give 24 (98 rng，8ヰ号る)会 
Cellculture. Hurnan oral squ註 mouscell carcinoma (HSC-2) cells human 
salivary gla詰 dtumor (HSG) cel主総 dhum註 ngingival fibroblast (HGF) 
(7-9th passage) were cultured in DMEM medium supplement叙 IwIth 
10% hcat-inactivated FBS in a humidified 5% C02 atmosphere. H縫 man 
promyelocytic leukernia H 1.-60 cells were cultured in RPMI1 640 
medium suppleme卦 tedwith 10% FBS (16). 
Assayfor cytotoxic activity. Near confluent HSC-2， HSG and HGF cells 
grow註 in96-microwell plates (Falcon，flat bottom，treated polystyrene， 
Becton ひた kenson) were incubated for 24 hours with various 
concentrations of sarnples. The cells were w註 shedwith phosphateω 
buffered salinc and incubated for 4 hours with frωh culture medium 
containing 0.2 rng/mL MTT. After r忍 movingthe rnedium，the cells were 
lysed with 100梓 IDMSO and the relative vi註 blecel number was 
deterrnined by measuring tl:!.e aち sorbanceat 540 nrn of the cel Iysate 
withい bsystem Multおむよ (Bioぬ rornatic) with Star!DOT Matrix 
Printer 11..10. The 50% cytoto主 cconcentration (CCso) was determined 
from the dose-responsecurve (7). 
Assay for redo.λpotential. Cornpou設 ds7，14，18 or 23 (final: 50 f.Lg/野 lL)
msupplemented with 10% FBS出of DMEM med 1. were added to 10 m
and mixed by constant stiri詰 gwith a magnet stirrer. τhe redox 
potential was measured at the indicated time points thcreafter with NO 
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monitor (1詰 terM吋 icaJCo.，Ltd.，Nagoya，Japan)総 dexpressed as the 
守diference (t.m V) from the initiaJ valω(17) 自 SG HL-6事 
ASSiぴ forDNA 弁'agm開 tation. The cels were peleted，lysed and dige 
sted wIth RNase A and protcinase K. DNA was isolated and assayed for 
DNA.fragmentation by 2% ag議 rosegeJ electrophoresis (16). DNA from 
1 2 3 4 S 6 7 8 9 10apoptotic Hし紛 celsinduωd byむ Viradiation (18) was run in paralel 
as a positive control. 
Result器 and Discussion 
not show蹴当 tum印刷 specificactio仏 butinduc芯 dDNA 
Among 24 compounds，cωompo∞む n凶d2 5(伊3お
含2-ph沈悶釘叩 奴 zol色吟) 総 8tcy悦 tm 荏 cti泌Vcnηザy柏 nida showed the hi怒喜 he 戸to 刻jc 寸i勾砂
a 渋ttwo humar 俗 s(HSC-2， HSG)略g荏幻iロ部s 設I0ωf詰 1 tumor cel line
(CCso=27説 nd18 m g!mL， respectively) (Table 1). Com-
pounds 7 (2・(2-hydroxybenzoyl)b叩 zimidazo[2，1-b]thi設定。 le) 
(CCSO口 52， 42ド.glmL)， 14 (1，3-diethylふ (2-hydroxybenzoyl)ー
ヰイ midazolineふ thione)(CCso=59，35 jlglmL) and 18 (5・(2-
hydroxy斗 methmゆ enzoyl)-3-methyl2-methylimino-4-剛 
!mL)showed slightly lower cyto料名13，C50=149(亡 thiazoline) 蜘 
toxic activity. 
Tumor specifiε1今 Wefound that normal fibroblasts (HGF 
cels) were relatively resi吉 tantto compounds 7，14 and 18 
but，respectively，and 2.7.42.5，3(C!A)(tumor specific ratio 口 
highly sensitive to ∞ mpound 23 (CIA=0.89) (Table 1). 0捻 
the other hand， hum註 npromyelocytic leu主emicHL駒 60cels 
>40.0 .2，5!B=l1，4 compounds (Cwere very sensitive to alI 
and 5ゑ respectively)(Table 1). 
Effect of antioxidants and metα，ls. It was of interest to test the 
possibility th紙記 ompound23 might induce cytotoxicity by its 
prooxidant註 ction.Table 1I shows that thεcytotoxic activity 
of ∞ mpound 23 was not significanty affected by the optimum 
concentrations of antioxidants，such as NAC (4 mM)，sodium 
ascorbate (0.25 mM) or cat註 lase(3，000 unit/mL) (which 
decomposes hydrogen peroxide). These data reduced the 
possibili句rof prooxidant action of compound 23. Among 3 
metals investigated， only CUCl2 significant砂 (5・お ld) 
enhanced th己 cytotoxicactivity of compound 23，whereas 
COCl2 and FeCl3 were inactive (Table I). 
lnduction of DNA介'agmentation. Agarose gel electrophoresis 
showed that compound 23 dose-dependently induced DNA 
fragmentation in HL-60ωlls，but not in HSG cels (Figure 2). 
However，there was a narrow range of optimal concentr邑 tion，
詰 ndhigher and lower concεntrations failed to induce DNA 
fragment以 ion. These data suggested that the response to 
compound 23 might be di首位 entfrom cel to cel. 
Among 24 compounds， we selected four cytoto必 c 
compounds 7，14，18 and 23Compounds7，14，18 selectively 禽 
kiled the tumor cells.γhe most cytotoxic compound 23 did 




(A) Near 23.gmentatiollby compoulld 均lnduction of DNA j 2. Figure 
cOllfluellt HSG cels (laleふ 5)and HL繍 60cels (lx10V lmL) (lanes 7-1の 
(B) were incubated for 6hours with 0 (control) (lal悶 Z乃，20(lanesえの 
40 (lalles 4，9) or 80 (1， 10) μ:glmLof compound 23. DNA wαS thel 朗自主 
extr.αcted and subjected to 2% agarose gel electrophoresis. Lalles 1 alld 6 
are the DNA fro例 apopto丘 cHL60cels illduced by UV irradiatioll (18)ω 
also found that CUC12 enhan edthe cytotoxic activity of ，む 
compoむ nd23 by a yet unknown mechanism. We have recently 
found that CuClz slightly enhancξ:d the cytotoxic activity of 4・ 
chloro-3，4-dihydro-2-(2-oxoふ phenylethyl)ー l-benzothiepinふ 
one and 2，3-dihydroふ。慨 opropyl)ふ phenylふ benzoxepi設 
(8). There might be common stimulation mechanisms 
between thesεcompounds. Further studies of the mechanism 
of their cytotoxic action are under way in our laboratory. 
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